Clinicopathological characteristics of oral squamous cell carcinoma in Northern Norway: a retrospective study

BMC Oral Health

Sonja E Steigen²  Elin Hadler-Olsen²  Lars Uhlin-Hansen²  Inger-Heidi Bjerkli¹  Oddveig G Rikardsen³ 

[1] Department of Otorhinolaryngology, University Hospital of North Norway, Tromsø, Norway;Diagnostic Clinic – Clinical Pathology, University Hospital of North Norway, Tromsø, Norway;Department of Medical Biology - Tumour Biology Research Group, UiT The Arctic University of Norway, Tromsø, Norway

关键词: Gender;    Primary site;    Alcohol;    Smoking;    Oral squamous cell carcinoma;   

Others  :  1109576
DOI  :  10.1186/1472-6831-14-103

 received in 2014-04-05, accepted in 2014-07-30,  发布年份 2014

【 摘 要 】

Background

The main aim of the study was to evaluate if patients with oral squamous carcinomas in Northern Norway differ from patients in other countries with regard to clinicopathological characteristics and also study the influence of risk factors. Such a comparison is of demographical interest, and also important for the interpretation of result from studies on prognostic biomarkers.

Methods

We describe clinicopathological characteristics of 133 North Norwegian patients diagnosed with squamous cell carcinoma of the oral cavity in the period 1986–2002, and evaluate the significance of different risk factors.

Results

The cohort consisted of 69 men and 64 women, giving male/female ratio of 1.1. Forty-seven of the 133 patients (35%) died of the disease within 5 years from diagnosis. There was no significant difference between the genders concerning time to disease specific death, even though men both smoked and drank more alcohol than women. As expected, the strongest predictors for disease specific death were tumour size and the presence of regional lymph node metastasis. We also found that heavy smokers and drinkers presented with more advanced disease, more often localized to the floor of mouth compared to non-smoking and abstinent patients, who more often presented with tumours of the mobile tongue.

Conclusions

Our results correlate well with previously published clinicopathological data on comparable cohorts, which is important when considering the applicability of results from biomarker studies performed on this material compared to other cohorts, and vice versa.

【 授权许可】

   
2014 Rikardsen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Barnes LEJ, Reichart P, Sidransky D: WHO. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005.
• [2]Davies AN, Epstein JB: Oral Complications of Cancer and its Management. New York: Oxford University press; 2010.
• [3]Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009, 45(4–5):309-316.
• [4]Oral cancer Incidence Statistics Cancer Research UK 2010. http://www.cancerresearchuk.org webcite
• [5]Cancer Registry of Norway: Cancer in Norway 2011 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2013.
• [6]Warnakulasuriya S: Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 2010, 46(6):407-410.
• [7]La Vecchia C, Lucchini F, Negri E, Levi F: Trends in oral cancer mortality in Europe. Oral Oncol 2004, 40(4):433-439.
• [8]Franceschi S, Bidoli E, Herrero R, Muñoz N: Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000, 36(1):106-115.
• [9]Ferreira Antunes JL, Toporcov TN, Biazevic MG, Boing AF, Scully C, Petti S: Joint and independent effects of alcohol drinking and tobacco smoking on oral cancer: a large case–control study. PLoS One 2013, 8(7):e68132.
• [10]Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, et al.: Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007, 99(10):777-789.
• [11]Castellsague X, Quintana MJ, Martinez MC, Nieto A, Sanchez MJ, Juan A, Monner A, Carrera M, Agudo A, Quer M, Muñoz N, Herrero R, Franceschi S, Bosch FX: The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004, 108(5):741-749.
• [12]Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D: Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999, 109(10):1544-1551.
• [13]Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48(11):3282-3287.
• [14]Guha N, Warnakulasuriya S, Vlaanderen J, Straif K: Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer 2014, 135(6):1433-1443.
• [15]IARC: International Agency for Research on Cancer. Betel-Quid and Areca-Nut Chewing and Ome Areca-Nut Derived Nitrosamines. In IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Volume 85. Lyon: IARC; 2004.
• [16]Shenoi R, Devrukhkar V, Sharma BK, Sapre SB, Chikhale A: Demographic and clinical profile of oral squamous cell carcinoma patients: a retrospective study. Indian J Cancer 2012, 49(1):21-26.
• [17]Boffetta P, Mashberg A, Winkelmann R, Garfinkel L: Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx. Int J Cancer 1992, 52(4):530-533.
• [18]Dhar PK, Rao TR, Sreekumaran Nair N, Mohan S, Chandra S, Bhat KR, Rao K: Identification of risk factors for specific subsites within the oral and oropharyngeal region–a study of 647 cancer patients. Indian J Cancer 2000, 37(2–3):114-122.
• [19]Sobin L, Gospodarowicz M, Wittekind C: TNM Classification of Malignant Tumours. 7th edition. Chichester: Wiley-Blackwell; 2009.
• [20]Leemans CR, Braakhuis BJ, Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11(1):9-22.
• [21]Massano J, Regateiro FS, Januário G, Ferreira A: Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102(1):67-76.
• [22]Chen YK, Huang HC, Lin LM, Lin CC: Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999, 35(2):173-179.
• [23]Kademani D, Bell RB, Bagheri S, Holmgren E, Dierks E, Potter B, Homer L: Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg 2005, 63(11):1599-1605.
• [24]Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, Yuen WF, Wei WI: Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002, 24(6):513-520.
• [25]Oc P, Pillai G, Patel S, Fisher C, Archer D, Eccles S, Rhys-Evans P: Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 2003, 39(4):386-390.
• [26]Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, Lugli A, Wolfensberger M, Terracciano LM: p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010, 21(10):1961-1966.
• [27]Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA: Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res: J Am Assoc Cancer Res 2002, 8(5):1203-1209.
• [28]Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344(15):1125-1131.
• [29]Poling JS, Ma XJ, Bui S, Luo Y, Li R, Koch WM, Westra WH: Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol 2014, 50(4):306-310.
• [30]Singhi AD, Westra WH: Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010, 116(9):2166-2173.
• [31]El-Naggar AK, Westra WH: p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 2012, 34(4):459-461.
• [32]Fregonesi PA, Teresa DB, Duarte RA, Neto CB, de Oliveira MR, Soares CP: p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 2003, 51(10):1291-1297.
• [33]International Classification of Diseases for Oncology 3rd edition. WHO; 2000. http://whqlibdoc.who.int/publications/2000/9241545348_eng.pdf webcite
• [34]Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haler DG, Morrow M: AJCC Cancer Staging Manual. 6th edition. New York: NY: Springer; 2002.
• [35]Muller S, Pan Y, Li R, Chi AC: Changing trends in oral squamous cell carcinoma with particular reference to young patients: 1971–2006. The Emory University experience. Head Neck Pathol 2008, 2(2):60-66.
• [36]Wang C, Xue H, Wang Q, Hao Y, Li D, Gu D, Huang J: Effect of drinking on all-cause mortality in women compared with men: a meta-analysis. J Women's Health 2002, 2014:373-381.
• [37]Blomberg M, Nielsen A, Munk C, Kjaer SK: Trends in head and neck cancer incidence in Denmark, 1978–2007: focus on human papillomavirus associated sites. Int J Cancer 2011, 129(3):733-741.
• [38]Rossow I: Drug consumtion in Norway (in Norwegian). Norsk Epidemiologi 2002, 12(3):301-307.
• [39]Strand BH, Steiro A: Alcohol consumption by level og income and education in Norway 1993–2000 (in Norwegian). Tidsskrift for Den norske legeforening 2003, 123(20):2849-2853.
• [40]De Stefani E, Boffetta P, Oreggia F, Fierro L, Mendilaharsu M: Hard liquor drinking is associated with higher risk of cancer of the oral cavity and pharynx than wine drinking. A case–control study in Uruguay. Oral Oncol 1998, 34(2):99-104.
• [41]Oze I, Matsuo K, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Sasazuki S, Inoue M, Tsugane S: Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2011, 41(5):677-692.
• [42]Life Expectancy in Norway Norwegian Institute of Public Health; 2014. http://www.ssb.no/en/befolkning/statistikker/dode webcite
• [43]Cancer Survival: England and Wales, Less Common Cancers by Age Groups Office of National Statistics (ONS) 2005. http://www.ons.gov.uk webcite
• [44]Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: Cancer J Clin 2011, 61(4):212-236.
• [45]Salazar CR, Smith RV, Garg MK, Haigentz M Jr, Schiff BA, Kawachi N, Anayannis N, Belbin TJ, Prystowsky MB, Burk RD, Schlecht NF: Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. Head Neck Pathol 2013, 8(1):77-87.